Hel 13-5 TFA is a monomeric synthetic peptide based on the N-terminal fragment of human SP-B. Hel 13-5 TFA is mainly α-helical and consists of 13 hydrophobic amino acid residues and 5 hydrophilic amino acid residues. Hel 13-5 TFA can be combined with phospholipids for the development of a model system for pulmonary surfactant [1] [2].
References:
[1]. Nakahara H, et al. Pulmonary surfactant model systems catch the specific interaction of an amphiphilic peptide with anionic phospholipid[J]. Biophysical journal, 2009, 96(4): 1415-1429.
[2]. Nakahara H, et al. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with Surfacten (Surfactant TA)[J]. Langmuir, 2008, 24(7): 3370-3379.
References:
[1]. Nakahara H, et al. Pulmonary surfactant model systems catch the specific interaction of an amphiphilic peptide with anionic phospholipid[J]. Biophysical journal, 2009, 96(4): 1415-1429.
[2]. Nakahara H, et al. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with Surfacten (Surfactant TA)[J]. Langmuir, 2008, 24(7): 3370-3379.
















